Pzena Investment Management LLC Reduces Holdings in Helen of Troy Limited $HELE

Pzena Investment Management LLC lessened its position in shares of Helen of Troy Limited (NASDAQ:HELE) by 6.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 947,568 shares of the company’s stock after selling 63,188 shares during the quarter. Pzena Investment Management LLC’s holdings in Helen of Troy were worth $20,136,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the company. Wellington Management Group LLP lifted its position in shares of Helen of Troy by 159.2% during the 3rd quarter. Wellington Management Group LLP now owns 747,220 shares of the company’s stock valued at $18,830,000 after buying an additional 458,979 shares during the last quarter. Ameriprise Financial Inc. lifted its position in shares of Helen of Troy by 46.4% during the 3rd quarter. Ameriprise Financial Inc. now owns 658,928 shares of the company’s stock valued at $16,605,000 after buying an additional 208,850 shares during the last quarter. UBS Group AG lifted its position in shares of Helen of Troy by 386.0% during the 4th quarter. UBS Group AG now owns 616,992 shares of the company’s stock valued at $13,111,000 after buying an additional 490,031 shares during the last quarter. Invenomic Capital Management LP lifted its position in shares of Helen of Troy by 68.8% during the 3rd quarter. Invenomic Capital Management LP now owns 554,985 shares of the company’s stock valued at $13,986,000 after buying an additional 226,263 shares during the last quarter. Finally, RWWM Inc. lifted its position in shares of Helen of Troy by 167.1% during the 3rd quarter. RWWM Inc. now owns 515,176 shares of the company’s stock valued at $12,982,000 after buying an additional 322,315 shares during the last quarter.

Key Stories Impacting Helen of Troy

Here are the key news stories impacting Helen of Troy this week:

• Neutral Sentiment: Multiple entertainment and opinion pieces mention “Helen of Troy” in connection with Lupita Nyong’o’s casting in The Odyssey, which may be drawing extra attention to HELE but does not reflect a change in the company’s fundamentals. Lupita Nyong’o Responds to Backlash Over Helen of Troy Casting in The Odyssey
• Neutral Sentiment: The articles also discuss backlash, race, and casting debates around the film, which may increase chatter around the name “Helen of Troy” but has no direct operational impact on Helen of Troy Limited. ‘The Odyssey’ Star Lupita Nyong’o Responds to Racist Casting Backlash: ‘This Is a Mythological Story’
• Negative Sentiment: If investors confuse the entertainment headlines with the consumer products company, that could add noise and volatility without any real business catalyst for HELE. Lupita Nyong’o Is ‘Honored’ to Be Your Helen of Troy

Analyst Upgrades and Downgrades

HELE has been the topic of a number of recent research reports. Wall Street Zen raised Helen of Troy from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Zacks Research raised Helen of Troy from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 5th. Weiss Ratings restated a “sell (d-)” rating on shares of Helen of Troy in a research note on Friday, March 27th. UBS Group lifted their target price on Helen of Troy from $16.00 to $25.00 and gave the company a “neutral” rating in a report on Friday, April 24th. Finally, Canaccord Genuity Group increased their price target on shares of Helen of Troy from $18.00 to $23.00 and gave the stock a “hold” rating in a report on Friday, April 24th. Two investment analysts have rated the stock with a Strong Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $24.00.

Helen of Troy Price Performance

Shares of NASDAQ:HELE opened at $24.79 on Friday. The company’s fifty day moving average price is $19.14 and its 200-day moving average price is $19.03. The firm has a market capitalization of $576.62 million, a price-to-earnings ratio of -0.63 and a beta of 1.29. Helen of Troy Limited has a one year low of $13.85 and a one year high of $33.73. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.71 and a quick ratio of 0.81.

Helen of Troy (NASDAQ:HELE) last issued its quarterly earnings results on Thursday, April 23rd. The company reported $0.83 EPS for the quarter, topping analysts’ consensus estimates of $0.74 by $0.09. The firm had revenue of $470.03 million for the quarter, compared to analyst estimates of $450.38 million. Helen of Troy had a negative net margin of 50.33% and a positive return on equity of 7.00%. The business’s revenue for the quarter was down 3.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.33 EPS. Helen of Troy has set its FY 2027 guidance at 3.250-3.750 EPS. On average, equities research analysts anticipate that Helen of Troy Limited will post 2.81 earnings per share for the current fiscal year.

Helen of Troy Profile

Helen of Troy Limited is a global consumer products company that designs, sources and markets a diversified portfolio of household, health and beauty brands. Headquartered in El Paso, Texas, the company operates through three principal segments—Health & Home, Housewares and Beauty—offering products under well-known names including OXO, Vicks, Braun, Honeywell Home, PUR and Hot Tools. Helen of Troy distributes its products through a combination of mass, specialty and e-commerce channels to consumers, retailers and distributors worldwide.

The Housewares segment features kitchen tools, gadgets and organizational solutions marketed primarily under the OXO brand, recognized for its ergonomic “Good Grips” design.